# Meropenem

NDC: 68001-323
Generic name: Meropenem
Labeler / Manufacturer: BluePoint Laboratories
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20170430

FDA application: ANDA205883

## Active ingredients

- MEROPENEM: 500 mg/20mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68001-323"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68001-323
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ca5f501c-6520-4d09-aae2-4f5db74d468f